Association of major histocompatibility complex class I chain-related gene A microsatellite polymorphism and hepatocellular carcinoma in South China Han population

Tissue Antigens

Volumn 78, Issue 2, 2011, Pages 143-147

  Jiang, X ^a,b   Zou, Y ^a   Huo, Z ^a   Yu, P ^a  

^a Central South University   (China)

^b THE FIRST AFFILIATED HOSPITAL OF UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Hepatocellular carcinoma; Soluble mica; Tumor immunosurveillance

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I RELATED GENE A; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHINA; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; HUMAN; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; PRIORITY JOURNAL;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHINA; ETHNIC GROUPS; FEMALE; GENES, MHC CLASS I; GENETIC PREDISPOSITION TO DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 79959975633     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2011.01693.x     Document Type: Article

References (36)

1. Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001: 2: 533-43.
2. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004: 127 (5 Suppl 1): S5-16.
3. Tang ZY. Hepatocellular carcinoma. J Gastroenterol Hepatol 2000: 15 (Suppl): G1-7.
4. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005: 55: 74-108.
5. Hall AJ, Wild CP. Liver cancer in low and middle income countries. BMJ 2003: 326: 994-5.
6. Chen CJ, Yu MW, Liaw YF. Epidemiological characteristics and risk factors of hepatocellular carcinoma. J Gastroenterol Hepatol 1997: 12: S294-308.
7. Yu MW, Chang HC, Liaw YF et al. Familial risk of hepatocellular carcinoma among chronic hepatitis B carriers and their relatives. J Natl Cancer Inst 2000: 92: 1159-64.
8. Bataller R, North KE, Brenner DA. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 2003: 37: 493-503.
9. Fodil N, Laloux L, Wanner V et al. Allelic repertoire of the human MHC class I MICA gene. Immunogenetics 1996: 44: 351-7.
10. Perez-Rodriguez M, Corell A, Argüello JR et al. A new MICA allele with ten alanine residues in the exon 5 microsatellite. Tissue Antigens 2000: 55: 162-5.
11. Ota M, Katsuyama Y, Mizuki N et al. Trinucleotide repeat polymorphism within exon 5 of the MICA gene (MHC class I chain-related gene A): allele frequency data in the nine population groups Japanese, Northern Han, Hui, Uygur, Kazakhstan, Iranian, Saudi Arabian, Greek and Italian. Tissue Antigens 1997: 49: 448-54.
12. Novota P, Kolostova K, Pinterova D et al. Association of MHC class I chain related gene-A microsatellite polymorphism with the susceptibility to T1DM and LADA in Czech adult patients. Int J Immunogenet 2005: 32: 273-5.
13. Singal DP, Li J, Zhang G. Microsatellite polymorphism of the MICA gene and susceptibility to rheumatoid arthritis. Clin Exp Rheumatol 2001: 19: 451-2.
14. Fojtikova M, Novota P, Cejková P et al. HLA class II, MICA and PRL gene polymorphisms: the common contribution to the systemic lupus erythematosus development in Czech population. Rheumatol Int 2010 [Epub ahead of print].
15. Groh V, Steinle A, Bauer S, Spies T. Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta T cells. Science 1998: 279: 1737-40.
16. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T. Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci U S A 1999: 96: 6879-84.
17. Vetter CS, Groh V, thor Straten P, Spies T, Bröcker EB, Becker JC. Expression of stress-induced MHC class I related chain molecules on human melanoma. J Invest Dermatol 2002: 118: 600-5.
18. Jinushi M, Takehara T, Tatsumi T et al. Expression and role of MICA and MICB in human hepatocellular carcinomas and their regulation by retinoic acid. Int J Cancer 2003: 104: 354-61.
19. Wu J, Song Y, Bakker AB et al. An activating immunoreceptor complex formed by NKG2D and DAP10. Science 1999: 285: 730-2.
20. Groh V, Wu J, Yee C, Spies T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 2002: 419: 734-8.
21. Salih HR, Rammensee HG, Steinle A. Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding. J Immunol 2002: 169: 4098-102.
22. Mizuki N, Ota M, Kimura M et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behcet disease. Proc Natl Acad Sci U S A 1997: 94: 1298-303.
23. Salih HR, Antropius H, Gieseke F et al. Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 2003: 102: 1389-96.
24. Groh V, Smythe K, Dai Z, Spies T. Fas-ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity. Nat Immunol 2006: 7: 755-62.
25. Kohga K, Takehara T, Tatsumi T et al. Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma. Cancer Sci 2008: 99: 1643-9.
26. Zou Y, Yang X, Jiang X et al. High levels of soluble major histocompatibility complex class I related chain A (MICA) are associated with biliary cast syndrome after liver transplantation. Transpl Immunol 2009: 21: 210-4.
27. Guo SW, Thompson EA. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 1992: 48: 361-72.
28. Tamaki S, Kawakami M, Yamanaka Y et al. Relationship between soluble MICA and the MICA A5.1 homozygous genotype in patients with oral squamous cell carcinoma. Clin Immunol 2009: 130: 331-7.
29. Tamaki S, Sanefuzi N, Ohgi K et al. An association between the MICA-A5.1 allele and an increased susceptibility to oral squamous cell carcinoma in Japanese patients. J Oral Pathol Med 2007: 36: 351-6.
30. Tian W, Zeng XM, Li LX et al. Gender-specific associations between MICA-STR and nasopharyngeal carcinoma in a southern Chinese Han population. Immunogenetics 2006: 58: 113-21.
31. Lavado-Valenzuela R, Benavides M, Carabantes F et al. MHC class I chain-related gene A transmembrane polymorphism in Spanish women with breast cancer. Tissue Antigens 2009: 74: 46-9.
32. Duan X, Deng L, Chen X et al. Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer. Med Oncol 2010 [Epub ahead of print].
33. Wu JD, Higgins LM, Steinle A, Cosman D, Haugk K, Plymate SR. Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer. J Clin Invest 2004: 114: 560-8.
34. Holdenrieder S, Stieber P, Peterfi A, Nagel D, Steinle A, Salih HR. Soluble MICA in malignant diseases. Int J Cancer 2006: 118: 684-7.
35. Lu M, Xia B, Ge L et al. Role of major histocompatibility complex class I-related molecules A*A5.1 allele in ulcerative colitis in Chinese patients. Immunology 2009: 128 (Suppl 1): e230-6.
36. Tamaki S, Kawakami M, Ishitani A et al. Soluble MICB serum levels correlate with disease stage and survival rate in patients with oral squamous cell carcinoma. Anticancer Res 2010: 30: 4097-101.